REACH drives the clinical practices and training programs at CARD. Our team approach enables us to comprehensively and innovatively explore child development and develop evidence-based treatments.
We are dedicated to translating research into treatments and educational practices. Funded by federal sources, including the National Institutes of Health (NIH), Institute of Education Sciences (IES), and private sources, much of our research is done in collaboration with other national and international experts. Some of our research includes:
- Early detection of ASD and other developmental disorders or delays
- Early diagnostic criteria
- Preventive intervention for infants and toddlers at risk of ASD and other developmental delay/disorders.
- Understanding and enhancing how children with ASD learn
- Effective methods for training caregivers and family members of children with ASD
- Effective methods to train childcare providers and teachers to meet the needs of neurodiverse children.
- Intervention for children with ASD
- Neuro-immune abnormalities in ASD
- Neurological basis of motor and attention impairments and the effects on communication
- Early abnormality in neurotransmitters and the effects on development
- Prevalence of ASD
- Environment-gene interactions
- Cholesterol abnormalities